Pneumonia due to other Gram-negative bacteria
ICD-10 J15.6 is a used to indicate a diagnosis of pneumonia due to other gram-negative bacteria.
Pneumonia due to other Gram-negative bacteria is a type of lung infection characterized by the inflammation of the lung parenchyma caused by various Gram-negative bacterial pathogens, excluding those specifically identified in other codes. Clinically, patients may present with symptoms such as cough, fever, chills, dyspnea, and pleuritic chest pain. The anatomy involved primarily includes the lungs, specifically the alveoli and bronchioles, where the infection leads to consolidation and impaired gas exchange. Disease progression can vary; in some cases, it may lead to severe respiratory distress or sepsis if not promptly treated. Diagnostic considerations include obtaining a thorough patient history, physical examination, and imaging studies such as chest X-rays or CT scans, along with microbiological cultures to identify the causative organism. Early identification and treatment are crucial to prevent complications and improve patient outcomes.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J15.6 covers pneumonia caused by various Gram-negative bacteria, including but not limited to Escherichia coli, Pseudomonas aeruginosa, and Acinetobacter species. It is essential to confirm the specific pathogen through laboratory testing.
J15.6 should be used when pneumonia is specifically due to Gram-negative bacteria not classified elsewhere. If the organism is identified and falls under a more specific code, that code should be used instead.
Documentation should include clinical findings, laboratory results confirming the presence of Gram-negative bacteria, imaging studies, and treatment plans. Clear notes on the patient's symptoms and response to treatment are also critical.
